Skip to main content
Top
Published in: Cost Effectiveness and Resource Allocation 1/2018

Open Access 01-12-2018 | Research

Factors associated with prescribing costs: analysis of a nationwide administrative database

Authors: O. Hirsch, M. Schulz, M. Erhart, N. Donner-Banzhoff

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2018

Login to get access

Abstract

Objective

All health care systems in the world struggle with rising costs for drugs. We sought to explore factors impacting on prescribing costs in a nationwide database of ambulatory care in Germany. Factors identified by this research can be used for adjustment in future profiling efforts.

Methods

We analysed nationwide prescription data of physicians having contractual relationships with statutory health insurance funds in 2014. Predictor and outcome variables were aggregated at the practice level. We performed analyses separately for primary care and specialties of cardiology, gastroenterology, neurology and psychiatry, pulmology as well as oncology and haematology. Bivariate robust regressions and Spearman rank correlations were computed in order to find meaningful predictors for our outcome variable prescription costs per patient.

Results

Median age of patients and proportion of DDD issued were substantial predictors for prescription costs per patient in Primary Care, Cardiology, and Pulmology with explained variances between 41 and 61%. In Neurology and Psychiatry only proportion of patients with polypharmacy ≥ 2 quarters was a significant predictor for prescription costs per patient, explaining 20% of the variance. For gastroenterologists, oncologists and haematologists no stable models could be established.

Conclusions

Any analysis of prescribing behaviour must take the degree into account to which an individual physician or practice is responsible for prescribing patients’ medication. Proportion of prescriptions/DDDs is an essential confounder for future studies of drug prescribing.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4–8.CrossRefPubMed Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4–8.CrossRefPubMed
5.
go back to reference Thomson S, Mossialos E. Primary care and prescription drugs: coverage, cost-sharing, and financial protection in six European countries. Issue Brief (Commonw Fund). 2010;82:1–14. Thomson S, Mossialos E. Primary care and prescription drugs: coverage, cost-sharing, and financial protection in six European countries. Issue Brief (Commonw Fund). 2010;82:1–14.
13.
go back to reference Rath M. Arzneimittelbudget und die neuen Arzneimittel-Richtlinien in der Wirtschaftlichkeitsprüfung [Drug budget and the new drug guidelines in economic analysis]. 1999;17:245–7. Rath M. Arzneimittelbudget und die neuen Arzneimittel-Richtlinien in der Wirtschaftlichkeitsprüfung [Drug budget and the new drug guidelines in economic analysis]. 1999;17:245–7.
14.
go back to reference Busse R, Schreyögg J, Henke K-D. Regulation of pharmaceutical markets in Germany: improving efficiency and controlling expenditures? Int J Health Plann Manage. 2005;20:329–49.CrossRefPubMed Busse R, Schreyögg J, Henke K-D. Regulation of pharmaceutical markets in Germany: improving efficiency and controlling expenditures? Int J Health Plann Manage. 2005;20:329–49.CrossRefPubMed
15.
go back to reference Reschke P, Sehlen S, Schiffhorst G, Schräder WF, Lauterbach KW, Wasem J. Klassifikationsmodelle für Versicherte im Risikostrukturausgleich. Berlin; 2004. Reschke P, Sehlen S, Schiffhorst G, Schräder WF, Lauterbach KW, Wasem J. Klassifikationsmodelle für Versicherte im Risikostrukturausgleich. Berlin; 2004.
16.
go back to reference Birnbaum HG, Cremieux PY, Greenberg PE, LeLorier J, Ostrander JA, Venditti L. Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics. 1999;16:1–8.CrossRefPubMed Birnbaum HG, Cremieux PY, Greenberg PE, LeLorier J, Ostrander JA, Venditti L. Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics. 1999;16:1–8.CrossRefPubMed
19.
go back to reference Rousseeuw PJ, Leroy AM. Robust regression and outlier detection. Hoboken: Wiley-Interscience; 2003. Rousseeuw PJ, Leroy AM. Robust regression and outlier detection. Hoboken: Wiley-Interscience; 2003.
20.
go back to reference Cohen J. Statistical power analysis for the behavioral sciences. Hoboken: Taylor and Francis; 1988. Cohen J. Statistical power analysis for the behavioral sciences. Hoboken: Taylor and Francis; 1988.
21.
go back to reference Tabachnick BG, Fidell LS. Using multivariate statistics. 6th ed. Harlow: Pearson; 2014. Tabachnick BG, Fidell LS. Using multivariate statistics. 6th ed. Harlow: Pearson; 2014.
23.
go back to reference Sleator DJ. Towards accurate prescribing analysis in general practice: accounting for the effects of practice demography. Br J Gen Pract. 1993;43:102–6.PubMedPubMedCentral Sleator DJ. Towards accurate prescribing analysis in general practice: accounting for the effects of practice demography. Br J Gen Pract. 1993;43:102–6.PubMedPubMedCentral
24.
go back to reference Lloyd DC, Harris CM, Roberts DJ. Specific therapeutic group age-sex related prescribing units (STAR-PUs): weightings for analysing general practices’ prescribing in England. BMJ. 1995;311:991–4.CrossRefPubMedPubMedCentral Lloyd DC, Harris CM, Roberts DJ. Specific therapeutic group age-sex related prescribing units (STAR-PUs): weightings for analysing general practices’ prescribing in England. BMJ. 1995;311:991–4.CrossRefPubMedPubMedCentral
25.
go back to reference Roe CM, McNamara AM, Motheral BR. Gender- and age-related prescription drug use patterns. Ann Pharmacother. 2002;36:30–9.CrossRefPubMed Roe CM, McNamara AM, Motheral BR. Gender- and age-related prescription drug use patterns. Ann Pharmacother. 2002;36:30–9.CrossRefPubMed
Metadata
Title
Factors associated with prescribing costs: analysis of a nationwide administrative database
Authors
O. Hirsch
M. Schulz
M. Erhart
N. Donner-Banzhoff
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Cost Effectiveness and Resource Allocation / Issue 1/2018
Electronic ISSN: 1478-7547
DOI
https://doi.org/10.1186/s12962-018-0091-1

Other articles of this Issue 1/2018

Cost Effectiveness and Resource Allocation 1/2018 Go to the issue